Oct 6, 2026 08:00AM
Oct 5, 2026 07:03AM
Sep 28, 2026 07:03AM
Sep 23, 2026 07:00AM
Aug 18, 2026 05:25PM
May 15, 2026 09:15AM
Apr 23, 2026 07:01AM Psyence BioMed begins dosing patients in phase IIb psilocybin trial
Apr 20, 2026 07:45AM
Apr 8, 2026 09:15AM
Mar 3, 2026 09:16AM
Feb 11, 2026 09:17AM
Dec 19, 2025 07:01AM
Nov 25, 2025 07:05AM
Nov 20, 2025 07:01AM Psyence BioMed secures ibogaine supply for clinical development
Nov 6, 2025 07:01AM
Oct 14, 2025 04:09PM
Aug 4, 2025 09:40AM
Jul 31, 2025 07:32AM
Jun 18, 2025 08:30AM
Jun 17, 2025 08:03AM
Jun 17, 2025 08:00AM Psyence Biomed Regains Full Compliance with NASDAQ Continued Listing Requirements
May 27, 2025 07:32AM
May 27, 2025 07:30AM
May 1, 2025 07:34AM
May 1, 2025 07:30AM
Apr 17, 2025 07:17PM
Apr 15, 2025 08:33AM
Apr 15, 2025 08:30AM Psyence BioMed Announces USD$500,000 Follow-On Investment in PsyLabs and Global Ibogaine Supply Agreement
Apr 8, 2025 08:00AM
Mar 31, 2025 08:00AM
Mar 18, 2025 08:36AM
Mar 18, 2025 08:30AM
Mar 10, 2025 11:25AM
Dec 23, 2024 08:03AM
Dec 23, 2024 07:31AM Psyence Biomedical (PBM) Regains Nasdaq Compliance
Dec 17, 2024 07:30AM
Nov 20, 2024 07:32AM
Nov 19, 2024 04:05PM
Oct 24, 2024 07:00AM
Oct 4, 2024 04:07PM
Sep 19, 2024 07:30AM
Sep 13, 2024 04:31PM Psyence Biomedical (PBM) Receives Nasdaq Staff Delisting Determination
Sep 6, 2024 07:30AM
Sep 4, 2024 07:31AM

462,683 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All